These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4873848)

  • 1. Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):103-10. PubMed ID: 4873848
    [No Abstract]   [Full Text] [Related]  

  • 2. Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):97-101. PubMed ID: 4873850
    [No Abstract]   [Full Text] [Related]  

  • 3. Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):89-96. PubMed ID: 4880891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demonstration of immunological differences between Graffi- and Gross-virus induced mouse leukemias in vivo and in vitro].
    Pasternak G; Hölzer B
    Neoplasma; 1965; 12(4):339-55. PubMed ID: 4285320
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.
    Woods WA; Wivel NA; Massicot JG; Chirigos MA
    Cancer Res; 1970 Aug; 30(8):2147-55. PubMed ID: 4918189
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants.
    Markham RV; Sutherland JC; Cimino EF; Drake WP; Mardiney MR
    Rev Eur Etud Clin Biol; 1972; 17(7):690-4. PubMed ID: 4119502
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to viral leukemia in rats and the routes of transmission from mother to offspring.
    Ioachim HL; Keller SE; Gimovsky ML; Shepherd S
    Cancer Res; 1973 Mar; 33(3):547-50. PubMed ID: 4570272
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-coded antigens in chemically induced leukemia.
    Pasternak G; Pasternak L
    Boll Ist Sieroter Milan; 1971; 50(3):192-8. PubMed ID: 5004411
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.
    Herberman RB; Oren ME
    J Natl Cancer Inst; 1971 Feb; 46(2):391-6. PubMed ID: 5115906
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration of skin in Gross leukemia. 3. Quantitation of the role of tumor cells.
    Mariani T; Maruyama Y; Good RA
    J Natl Cancer Inst; 1972 Feb; 48(2):363-6. PubMed ID: 4568966
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative leukemia: of mice and men.
    Pasqualini CD
    Medicina (B Aires); 1981; 41 Suppl():199-206. PubMed ID: 7345344
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies cross-reacting with Gross virus detected in human acute leukemia and Hodgkin lymphoma.
    Dosne Pasqualini C; Di Girolamo MT; Segal Eiras A; Laguens RP
    Medicina (B Aires); 1980; 40(3):289-94. PubMed ID: 7001168
    [No Abstract]   [Full Text] [Related]  

  • 19. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 20. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W; Festenstein H; Atfield G
    Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.